Johnson & Johnson (NYSE:JNJ) is included in our list of the 11 most overvalued companies according to the media.
Trong Nguyen / Shutterstock.com
Regarding a mesothelioma case, where a woman allegedly died from cancer caused by the company’s talc products, Johnson & Johnson faced a setback on March 16, 2026. That day, a California judge upheld $16 million in compensatory damages for causation. At the same time, the judge overturned a $950 million punitive damages award against the company.
An important factor in removing the punitive portion of the ruling was the court’s decision not to penalize Johnson & Johnson because there was insufficient evidence that the company behaved with malice or attempted to knowingly conceal risks.
However, Johnson & Johnson continues to be exposed to litigation. In this scenario, over 67,000 plaintiffs have claimed to have contracted cancer from using talc-based products, though only a few of these claims are for mesothelioma.
Meanwhile, Johnson & Johnson stated that it would appeal the court’s ruling on causation and compensatory damages.
Johnson & Johnson manufactures and markets healthcare products within the Innovative Medicine and MedTech sectors, emphasizing pharmaceuticals, medical devices, and surgical solutions, with its worldwide headquarters located in New Jersey.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
